Elligo Health Research: Funding, Investors & Team (Sep 2026)
Elligo Health Research is a healthcare company that revolutionizes the clinical research industry with a novel approach to common trial challenges including patient participation and enrollment, and physician participation. They provide physicians and their patients the opportunity to participate in clinical trials using advanced health care informatics. Improved access to physicians and patients means sponsors reach trial enrollment goals faster, and new products are accelerated to market, benefiting patients everywhere. It brings clinical research to physician practices, accelerating the development of pharmaceutical, biotechnology, and medical device products and therapies. Elligo Health Research was founded in 2016 and is headquartered in Austin, Texas.
Elligo Health Research has raised $135M across 1 funding round on record, the most recent a Series E of $135M announced in Sep 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Elligo Health Research Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Elligo Health Research Funding Rounds
Elligo Health Research Founders and Leadership Team
No contact details are on record for this team yet.
Elligo Health Research Funding Compared to Other Biotechnology Startups
Elligo Health Research's latest round of $135M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Elligo Health Research in Biotechnology and Austin
Companies Similar to Elligo Health Research
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Elligo Health Research Funding FAQs
What does Elligo Health Research do?
Elligo Health Research is a healthcare company that revolutionizes the clinical research industry with a novel approach to common trial challenges including patient participation and enrollment, and physician participation. They provide physicians and their patients the opportunity to participate in clinical trials using advanced health care informatics. Improved access to physicians and patients means sponsors reach trial enrollment goals faster, and new products are accelerated to market, benefiting patients everywhere. It brings clinical research to physician practices, accelerating the development of pharmaceutical, biotechnology, and medical device products and therapies. Elligo Health Research was founded in 2016 and is headquartered in Austin, Texas.
How much funding has Elligo Health Research raised?
Elligo Health Research has raised $135M across 1 round on record. The most recent is a Series E of $135M announced in Sep 2021.
When did Elligo Health Research last raise funding?
Elligo Health Research's most recent funding round on record is a Series E of $135M, announced in Sep 2021.
Who is the CEO of Elligo Health Research?
John Potthoff is listed as CEO at Elligo Health Research.
Where is Elligo Health Research headquartered?
Elligo Health Research is based in Austin, Texas, United States.
How many employees does Elligo Health Research have?
Elligo Health Research is in the 101-250 employee band.
How does Elligo Health Research's funding compare to other Biotechnology startups?
Elligo Health Research's latest round of $135M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Elligo Health Research Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Elligo Health Research is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.